Schrijvers D - Search Results

1

Activated oxazaphosphorines are transported predominantly by erythrocytes.

Highley MS, Schrijvers D, Van Oosterom AT, Harper PG, Momerency G, Van Cauwenberghe K, Maes RA, De Bruijn EA, Edelstein MB. Highley MS, et al. Among authors: schrijvers d. Ann Oncol. 1997 Nov;8(11):1139-44. doi: 10.1023/a:1008261203803. Ann Oncol. 1997. PMID: 9426334 Free article.

2

A phase II trial of dose-escalated doxorubicin and ifosfamide/mesna in patients with malignant mesothelioma.

Dirix LY, van Meerbeeck J, Schrijvers D, Corthouts B, Prové A, van Marck E, Vermeire P, van Oosterom AT. Dirix LY, et al. Among authors: schrijvers d. Ann Oncol. 1994 Sep;5(7):653-5. doi: 10.1093/oxfordjournals.annonc.a058941. Ann Oncol. 1994. PMID: 7993844 Free article. Clinical Trial.

3

The management of ovarian cancer.

Prové AM, Dirix LY, Schrijvers D, Van Oosterom AT. Prové AM, et al. Among authors: schrijvers d. Ann Oncol. 1993 Dec;4(10):883-7. doi: 10.1093/oxfordjournals.annonc.a058398. Ann Oncol. 1993. PMID: 8117609 Free article. No abstract available.

4

Role of red blood cells in pharmacokinetics of chemotherapeutic agents.

Schrijvers D, Highley M, De Bruyn E, Van Oosterom AT, Vermorken JB. Schrijvers D, et al. Anticancer Drugs. 1999 Feb;10(2):147-53. doi: 10.1097/00001813-199902000-00002. Anticancer Drugs. 1999. PMID: 10211544 Review.

5

Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic study.

Schrijvers D, Pronk L, Highley M, Bruno R, Locci-Tonelli D, De Bruijn E, Van Oosterom AT, Verweij J. Schrijvers D, et al. Am J Clin Oncol. 2000 Aug;23(4):358-63. doi: 10.1097/00000421-200008000-00010. Am J Clin Oncol. 2000. PMID: 10955864 Clinical Trial.

6

Coping with toxicities of docetaxel (Taxotere).

Schrijvers D, Wanders J, Dirix L, Prove A, Vonck I, van Oosterom A, Kaye S. Schrijvers D, et al. Ann Oncol. 1993 Aug;4(7):610-1. doi: 10.1093/oxfordjournals.annonc.a058599. Ann Oncol. 1993. PMID: 8103352 Free article. Clinical Trial.

7

Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I study.

Pronk LC, Schrijvers D, Schellens JH, de Bruijn EA, Planting AS, Locci-Tonelli D, Groult V, Verweij J, van Oosterom AT. Pronk LC, et al. Among authors: schrijvers d. Semin Oncol. 1998 Feb;25(1 Suppl 2):23-8. Semin Oncol. 1998. PMID: 9535208 Clinical Trial.

8

Late peritoneal metastasis in a patient with osteosarcoma.

Westra A, Schrijvers D, Somville J, Van Schil P, Hubens G, Van Oosterom A. Westra A, et al. Among authors: schrijvers d. Ann Oncol. 1998 Aug;9(8):907-11. doi: 10.1023/a:1008260216130. Ann Oncol. 1998. PMID: 9789615 Free article.

9

Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience.

van Oosterom AT, Schrijvers D, Schriivers D [corrected to Schrijvers D]. van Oosterom AT, et al. Among authors: schrijvers d. Anticancer Drugs. 1995 Jun;6(3):356-68. doi: 10.1097/00001813-199506000-00002. Anticancer Drugs. 1995. PMID: 7670133 Review.

10

KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic study.

Schrijvers D, Catimel G, Highley M, Höppener FJ, Dirix L, De Bruijn E, Droz JP, Van Oosterom AT. Schrijvers D, et al. Anticancer Drugs. 1999 Aug;10(7):633-9. doi: 10.1097/00001813-199908000-00002. Anticancer Drugs. 1999. PMID: 10507312 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters